Lyka Labs has informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 12th November, 2025, to consider and transact following major businesses: 1. To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the 2nd quarter and six months ended 30th September, 2025 alongwith Limited Review Report issued by Statutory Auditor of the Company; 2. To consider and approve shifting of the Registered Office of the Company from State of Gujarat to Maharashtra; 3. To consider and approve Notice of Extra-Ordinary General Meeting of the Company; 4. and any other Business. This is also being made available on the website of the Company at www.lykalabs.com.
The above information is a part of company’s filings submitted to BSE.
